The Pharma Legal Handbook: Singapore

Singapore is Southeast Asia's most advanced pharmaceutical market and a major hub for pharmaceutical manufacturing, research and regional headquarters operations. The Health Sciences Authority (HSA) administers a well-regarded regulatory framework that is highly aligned with international standards and participates actively in collaborative registration procedures.

Singapore's position as a regional hub means that many companies managing Southeast Asian portfolios choose Singapore as their base for regulatory, medical affairs and market access operations. The HSA's willingness to accept foreign clinical data and its participation in international regulatory initiatives makes it a more straightforward market to navigate than many in the region.

The Pharma Legal Handbook: Singapore provides comprehensive guidance on pharmaceutical regulation in Singapore, covering HSA product registration, pricing and reimbursement frameworks, clinical trial requirements, pharmacovigilance obligations, manufacturing and GMP requirements, marketing rules, and intellectual property protection.